Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Stock Exchange of Hong Kong  >  China Medical System Holdings Limited    0867   KYG211081248

CHINA MEDICAL SYSTEM HOLDINGS LIMITED

(0867)
  Report  
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsPress ReleasesOfficial PublicationsSector newsAnalyst Recommendations

China Medical System : Won “China Enterprise Excellence Awards- The Best Investor Relations”

share with twitter share with LinkedIn share with facebook
share via e-mail
0
09/12/2019 | 07:47am EST

China Medical System Won 'China Enterprise Excellence Awards- The Best Investor Relations'

On September 6, 2019, the first 'China Enterprise Excellence Awards Ceremony' was grandly held by Porda Havas International Finance Communications Group, AMO Group and Hong Kong International Investment Society at Hong Kong. China Medical System Holdings Limited (CMS) was awarded the 'The Best Investor Relations'.
'China Enterprise Excellence Awards' aims to honor the contributions and outstanding achievements made by Chinese business elites for China's business stride toward the globalization. A total of 300 enterprises participated in this event. Amongst, selected by the authoritative representatives of investment society and professional institutions, 'The Best Investor Relations' is awarded to well-known enterprises with excellent reputation and remarkable investor relations based on their performance in the capital market.
In 2019, China's medical and pharmaceutical reform policies have been fully implemented and progressed. With its original aspiration, the Group continually accelerated the deployment of products that can meet the unmet medical needs of Chinese market with innovative research and development as its core strategy, while constantly upgrading and optimizing its promotion network, aiming to bring the sustainable development driving force for the Group. In order to enable the capital market to have a deeper insight into the Group's operation situation and future development strategy, the Group always disclosed the information important to shareholders and investors timely and objectively through multiple channels while conveying the Company's latest news to the capital market actively and effectively. Winning the award of 'China Enterprise Excellence Awards- The Best Investor Relations' reflects that the capabilities of the Company's investor relations team have been fully recognized by the capital market. Looking into the future, the Company will continue to maintain a mutual and transparent communication with the capital market and strive to maintain a good investor relationship, creating the continuous value for shareholders!

Disclaimer

China Medical System Holdings Ltd. published this content on 12 September 2019 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 12 September 2019 11:46:07 UTC

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on CHINA MEDICAL SYSTEM HOLDI
11/05CHINA MEDICAL SYSTEM : Voluntary and Business Update Announcement Related to Sig..
PU
10/14CHINA MEDICAL SYSTEM : CMS Wins Three Awards
PU
09/16CHINA MEDICAL SYSTEM : CMS Signed a License and Supply Agreement of Three Generi..
PU
09/13BIOCON : Licenses Three Generic Formulation Products to China Medical System Hol..
AQ
09/12CHINA MEDICAL SYSTEM : Voluntary and Business Update Announcement Sign a License..
PU
09/12CHINA MEDICAL SYSTEM : Won “China Enterprise Excellence Awards- The Best I..
PU
08/30CHINA MEDICAL SYSTEM : Notification letter
PU
08/30CHINA MEDICAL SYSTEM HOLDINGS : Ex-dividend day for interim dividend
FA
08/20CHINA MEDICAL SYSTEM : The Inclusion of Hirudoid? in the Medical Insurance Catal..
PU
08/19SUN PHARMACEUTICAL INDUSTRIES : Pharma and China Medical System Holdings Enter i..
AQ
More news
Financials (CNY)
Sales 2019 5 987 M
EBIT 2019 2 330 M
Net income 2019 2 193 M
Finance 2019 425 M
Yield 2019 3,19%
P/E ratio 2019 12,1x
P/E ratio 2020 11,4x
EV / Sales2019 4,39x
EV / Sales2020 3,75x
Capitalization 26 702 M
Chart CHINA MEDICAL SYSTEM HOLDINGS LIMITED
Duration : Period :
China Medical System Holdings Limited Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends CHINA MEDICAL SYSTEM HOLDI
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 13
Average target price 10,50  CNY
Last Close Price 10,77  CNY
Spread / Highest target 55,8%
Spread / Average Target -2,45%
Spread / Lowest Target -26,7%
EPS Revisions
Managers
NameTitle
Kong Lam Chairman, President & Chief Executive Officer
Hong Bing Chen Chief Operating Officer, Executive Director & VP
Yan Ling Chen Chief Financial Officer, Executive Director & VP
Wai Ming Wong Chief Technical Officer
Chi Keung Wu Independent Non-Executive Director